Global LDL Test Market - Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Publish Reports
  • Jun 2019
  • Global
  • 350 Pages
  • No of Tables: 53
  • No of Figures: 183
Global LDL Test Market By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026 Low density lipoprotein (LDL) is known as bad cholesterol because it is build-up of extra fat in arteries. This condition narrows the arteries and raises the risk of heart attack, stroke and peripheral artery disease. So for the determination of LDL, various kits, reagent and devices are used. For instance N-geneous LDL cholesterol calibrator which used as LDL test for determination of low density lipoprotein for measuring risk of heart diseases. It is basically for in-vitro diagnostic use. These circular particles serve to solubilize and transport cholesterol and triglyceride in the blood stream. The relative proportions of protein and lipid calculates the density of this lipoprotein. The test LDL cholesterol acts as a key factor for determine pathogenesis of atherosclerosis and coronary heart disease. By the use of this test can easily find out associated risk for heart diseases.

Global LDL test market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: Global LDL Test Market

Global LDL test market is segmented into four notable segments such as component, disease, end user, distribution channel.

  • On the basis of component, the market is segmented into devices, kits & reagents and services.
  • On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.

    • In November 2017, Sticssekisui Diagnostics (U.S.) received Canada top employer award. This award honor and show the commitment of employees as well as management for making Sekisui Diagnostics PEI a great place to work.

  • On the basis of distribution channel, the market is segmented into direct tenders and retail.

    • In October 2017, Abbott (U.S.) acquired Alere Laboratory (U.S.). Abbott paid USD 5.8 Billion to Alere and as per the agreement Alere has become subsidiary of Abbott. By this acquisition company enhance their business and capture more market share.

  • On the basis of end user, the market is segmented into hospitals, clinics, research laboratory, and ambulatory care.

Competitive Analysis: Global LDL Test Market

Some of the major players operating in this market are Quest Diagnostics, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckondiagnostics, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Abbott, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc., Laboratory Corporation of America, Cell Biolabs, Inc., Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc., Home Access Health and others.

Product Launch

  • In October 2018, Laboratory Corporation of America (U.S) enabled health record on iPhone. This feature is beneficial for patients to access their LabCorp laboratory test results, along with other available medical data from multiple providers. It enables the patients in receiving the notifications when their data is updated. Patients can access other convenient tools including appointments and payment of invoices as well. With this innovative technology, the company enhances their business.
  • In September 2017 Quest Diagnostics (U.S) entered into cholesterol testing for identifying the risk of heart disease and opt right treatment decision. The company’s cholesterol test services which include an innovative calculation method to improve the accuracy of testing for LDL level causing cardiovascular disease.
  • In February 2019 Randox Laboratories Ltd (U.K) launched a new website which provides information about the products. By this website potential customers can identify their product related information. This website launch is helpful in increasing the business awareness by providing easy way of learning about the company’s products and services.

Research Methodology: Global LDL Test Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE OF CONTENTS GLOBAL LDL TEST MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF GLOBAL LDL TEST MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GLOBAL LDL TEST MARKET: GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 DBMR MARKET POSITION GRID 2.7 DBMR MARKET CHALLENGE MATRIX 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 KEY PRIMARY INSIGHTS 2.12 SECONDARY SOURCES 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING AWARENESS AMONG PATIENT 3.1.2 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND OBESITY 3.1.3 INCREASING NUMBER OF GERIATRIC PEOPLE 3.1.4 GOVERNMENT INITIATIVES TO IMPROVE QUALITY OF TESTING

3.2 RESTRAINTS

3.2.1 RISKS ASSOCIATED WITH TESTS LIKE BLEEDING AND INFECTION 3.2.2 EMERGENCE OF NON-INVASIVE CHOLESTEROL TESTING METHODS

3.3 OPPORTUNITIES

3.3.1 HIGH GROWTH POSSIBILITY IN LDL TEST IN DEVELOPING COUNTRIES 3.3.2 PATIENT-INITIATED TESTING

3.4 CHALLENGES

3.4.1 PATIENT DATA SECURITY 3.4.2 EVOLVING REGULATORY POLICIES

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 GLOBAL LDL TEST MARKET, BY COMPONENTS

6.1 OVERVIEW 6.2 KITS & REAGENTS 6.3 DEVICES

6.3.1 SPECTROPHOTOMETER 6.3.2 SYRINGES AND NEEDLES 6.3.3 OTHERS

6.4 SERVICES

7 GLOBAL LDL TESTING MARKET, BY DISEASE

7.1 OVERVIEW 7.2 DIABETES 7.3 STROKE 7.4 ATHEROSCLEROSIS 7.5 OBESITY 7.6 DYSLIPIDEMIA 7.7 CAROTID ARTERY DISEASE 7.8 PERIPHERAL ARTERIAL DISEASE 7.9 ANGINA 7.10 OTHERS

8 GLOBAL LDL TEST MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW 8.2 DIRECT TENDERS 8.3 RETAIL

9 GLOBAL LDL TEST MARKET, BY END USER

9.1 OVERVIEW 9.2 HOSPITALS 9.3 CLINICS 9.4 AMBULATORY CARE 9.5 RESEARCH LABORATORY

10 GLOBAL LDL TEST MARKET, BY GEOGRAPHY

10.1 OVERVIEW 10.2 NORTH AMERICA

10.2.1 U.S. 10.2.2 CANADA 10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY 10.3.2 U.K 10.3.3 FRANCE 10.3.4 ITALY 10.3.5 SPAIN 10.3.6 SWITZERLAND 10.3.7 NETHERLANDS 10.3.8 RUSSIA 10.3.9 BELGIUM 10.3.10 TURKEY 10.3.11 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA 10.4.2 JAPAN 10.4.3 INDIA 10.4.4 AUSTRALIA 10.4.5 SOUTH KOREA 10.4.6 SINGAPORE 10.4.7 MALAYSIA 10.4.8 INDONESIA 10.4.9 THAILAND 10.4.10 PHILIPPINES 10.4.11 REST OF ASIA-PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL 10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST AND AFRICA

10.6.1 SOUTH AFRICA 10.6.2 REST OF MIDDLE EAST AND AFRICA

11 GLOBAL LDL TEST MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: GLOBAL 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 11.3 COMPANY SHARE ANALYSIS: EUROPE 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 SWOT ANALYSIS

12.1 STRENGTH 12.2 WEAKNESS 12.3 OPPORTUNITY 12.4 THREAT 12.5 DATA BRIDGE MARKET RESEARCH ANALYSIS

13 COMPANY PROFILE

13.1 F. HOFFMANN-LA ROCHE LTD

13.1.1 COMPANY SNAPSHOT 13.1.2 REVENUE ANALYSIS 13.1.3 COMPANY SHARE ANALYSIS 13.1.4 GEOGRAPHICAL PRESENCE 13.1.5 PRODUCT PORTFOLIO 13.1.6 RECENT DEVELOPMENTS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT 13.2.2 REVENUE ANALYSIS 13.2.3 COMPANY SHARE ANALYSIS 13.2.4 GEOGRAPHICAL PRESENCE 13.2.5 PRODUCT PORTFOLIO 13.2.6 RECENT DEVELOPMENT

13.3 ABBOTT

13.3.1 COMPANY SNAPSHOT 13.3.2 REVENUE ANALYSIS 13.3.3 COMPANY SHARE ANALYSIS 13.3.4 GEOGRAPHICAL PRESENCE 13.3.5 PRODUCT PORTFOLIO 13.3.6 RECENT DEVELOPMENTS

13.4 SEKISUI DIAGNOSTICS

13.4.1 COMPANY SNAPSHOT 13.4.2 COMPANY SHARE ANALYSIS 13.4.3 GEOGRAPHICAL PRESENCE 13.4.4 PRODUCT PORTFOLIO 13.4.5 RECENT DEVELOPMENT

13.5 ATLAS MEDICAL U.K

13.5.1 COMPANY SNAPSHOT 13.5.2 GEOGRAPHICAL PRESENCE 13.5.3 PRODUCT PORTFOLIO 13.5.4 RECENT DEVELOPMENTS

13.6 CELL BIOLABS, INC

13.6.1 COMPANY SNAPSHOT 13.6.2 GEOGRAPHICAL PRESENCE 13.6.3 PRODUCT PORTFOLIO 13.6.4 RECENT DEVELOPMENTS

13.7 DIASYS DIAGNOSTIC SYSTEMS GMBH

13.7.1 COMPANY SNAPSHOT 13.7.2 GEOGRAPHICAL PRESENCE 13.7.3 PRODUCT PORTFOLIO 13.7.4 RECENT DEVELOPMENT

13.8 DIAZYME LABORATORIES, INC

13.8.1 COMPANY SNAPSHOT 13.8.2 GEOGRAPHICAL PRESENCE 13.8.3 PRODUCT PORTFOLIO 13.8.4 RECENT DEVELOPMENTS

13.9 EUROFINS SCIENTIFIC

13.9.1 COMPANY SNAPSHOT 13.9.2 REVENUE ANALYSIS 13.9.3 GEOGRAPHICAL PRESENCE 13.9.4 PRODUCT PORTFOLIO 13.9.5 RECENT DEVELOPMENT

13.10 EUROLYSER DIAGNOSTICA GMBH

13.10.1 COMPANY SNAPSHOT 13.10.2 GEOGRAPHICAL PRESENCE 13.10.3 PRODUCT PORTFOLIO

13.10.1 RECENT DEVELOPMENTS

13.11 EXPRESS BIOTECH INTERNATIONAL

13.11.1 COMPANY SNAPSHOT 13.11.2 GEOGRAPHICAL PRESENCE 13.11.3 PRODUCT PORTFOLIO 13.11.4 RECENT DEVELOPMENTS

13.12 HOME ACCESS HEALTH

13.12.1 COMPANY SNAPSHOT 13.12.2 PRODUCT PORTFOLIO 13.12.3 RECENT DEVELOPMENTS

13.13 LABORATORY CORPORATION OF AMERICA

13.13.1 COMPANY SNAPSHOT 13.13.2 REVENUE ANALYSIS 13.13.3 GEOGRAPHICAL PRESENCE 13.13.4 PRODUCT PORTFOLIO 13.13.5 RECENT DEVELOPMENTS

13.14 QUEST DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT 13.14.2 REVENUE ANALYSIS 13.14.3 GEOGRAPHICAL PRESENCE 13.14.4 PRODUCT PORTFOLIO 13.14.5 RECENT DEVELOPMENT

13.15 RANDOX LABORATORIES LTD

13.15.1 COMPANY SNAPSHOT 13.15.2 GEOGRAPHICAL PRESENCE 13.15.3 PRODUCT PORTFOLIO 13.15.4 RECENT DEVELOPMENT

13.16 RECKONDIAGNOSTICS

13.16.1 COMPANY SNAPSHOT 13.16.2 PRODUCT PORTFOLIO 13.16.3 RECENT DEVELOPMENTS

13.17 THERMO FISHER SCIENTIFIC INC

13.17.1 COMPANY SNAPSHOT 13.17.2 REVENUE ANALYSIS 13.17.3 GEOGRAPHICAL PRESENCE 13.17.4 PRODUCT PORTFOLIO 13.17.5 RECENT DEVELOPMENTS

14 CONCLUSION 15 QUESTIONNAIRE 16 RELATED REPORTS
 

LIST OF TABLES GLOBAL LDL TEST MARKET

TABLE 1 GLOBAL LDL TEST MARKET, BY COMPONENTS, 2017– 2026 (USD MILLION) TABLE 2 GLOBAL KITS & REAGENTS IN GLOBAL LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 3 GLOBAL DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026, USD MILLION TABLE 4 GLOBAL DEVICES IN LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 5 GLOBAL SERVICES IN GLOBAL LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 6 GLOBAL LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 7 GLOBAL DIABETES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 GLOBAL STROKE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 GLOBAL ATHEROSCLEROSIS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 10 GLOBAL OBESITY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 GLOBAL DYSLIPIDEMIA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 GLOBAL CAROTID ARTERY DISEASE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 GLOBAL PERIPHERAL ARTERIAL DISEASES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 GLOBAL ANGINA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 GLOBAL OTHERS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 GLOBAL LDL TEST MARKET, BY DRISTIBUTION CHANNEL, 2017– 2026 (USD MILLION) TABLE 17 GLOBAL DIRECT TENTERS IN GLOBAL LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 18 GLOBAL RETAIL IN GLOBAL LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 19 GLOBAL LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 20 GLOBAL HOSPITALS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 21 GLOBAL CLINICS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 GLOBAL AMBULATORY CARE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 GLOBAL RESEARCH LABORATORY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 GLOBAL LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 NORTH AMERICA LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 26 NORTH AMERICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 27 NORTH AMERICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 28 NORTH AMERICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 29 NORTH AMERICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 30 NORTH AMERICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 31 U.S. LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 32 U.S. DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 33 U.S. LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 34 U.S. LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 35 U.S LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 36 CANADA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 37 CANADA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 38 CANADA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 39 CANADA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 40 CANADA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 41 MEXICO LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 42 MEXICO DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 43 MEXICO LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 44 MEXICO LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 45 MEXICO LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 46 EUROPE LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 47 EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 48 EUROPE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 49 EUROPE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 50 EUROPE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 51 EUROPE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 52 GERMANY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 53 GERMANY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 54 GERMANY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 55 GERMANY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 56 GERMANY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 57 U.K LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 58 U.K DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 59 U.K LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 60 U.K LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 61 U.K LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 62 FRANCE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 63 FRANCE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 64 FRANCE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 65 FRANCE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 66 FRANCE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 67 ITALY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 68 ITALY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 69 ITALY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 70 ITALY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 71 ITALY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 72 SPAIN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 73 SPAIN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 74 SPAIN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 75 SPAIN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 76 SPAIN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 77 SWITZERLAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 78 SWITZERLAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 79 SWITZERLAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 80 SWITZERLAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 81 SWITZERLAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 82 NETHERLANDS LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 83 NETHERLANDS DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 84 NETHERLANDS LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 85 NETHERLANDS LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 86 NETHERLANDS LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 87 RUSSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 88 RUSSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 89 RUSSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 90 RUSSIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 91 RUSSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 92 BELGIUM LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 93 BELGIUM DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 94 BELGIUM LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 95 BELGIUM LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 96 BELGIUM LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 97 TURKEY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 98 TURKEY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 99 TURKEY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 100 TURKEY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 101 TURKEY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 102 REST OF EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 103 ASIA-PACIFIC LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 104 ASIA-PACIFIC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 105 ASIA-PACIFIC DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 106 ASIA-PACIFIC LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 107 ASIA-PACIFIC LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 108 ASIA-PACIFIC LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 109 CHINA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 110 CHINA DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026 (USD MILLION) TABLE 111 CHINA DEVICES IN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 112 CHINA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 113 CHINA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 114 JAPAN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 115 JAPAN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 116 JAPAN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 117 JAPAN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 118 JAPAN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 119 INDIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 120 INDIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 121 INDIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 122 INDIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 123 INDIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 124 AUSTRALIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 125 AUSTRALIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 126 AUSTRALIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 127 AUSTRALIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 128 AUSTRALIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 129 SOUTH KOREA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 130 SOUTH KOREA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 131 SOUTH KOREA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 132 SOUTH KOREA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 133 SOUTH KOREA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 134 SINGAPORE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 135 SINGAPORE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 136 SINGAPORE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 137 SINGAPORE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 138 SINGAPORE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 139 MALAYSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 140 MALAYSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 141 MALAYSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 142 MALAYSIA LDL TEST MARKET, BY DISTRIBUTION CHAANEL, 2017-2026 (USD MILLION) TABLE 143 MALAYSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 144 INDONESIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 145 INDONESIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 146 INDONESIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 147 INDONESIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 148 INDONESIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 149 THAILAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 150 THAILAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 151 THAILAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 152 THAILAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 153 THAILAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 154 PHILIPPINES LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 155 PHILIPPINES DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 156 PHILIPPINES LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 157 PHILIPPINES LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 158 PHILIPPINES LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 159 REST OF APAC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 160 SOUTH AMERICA LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 161 SOUTH AMERICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 162 SOUTH AMERICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 163 SOUTH AMERICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 164 SOUTH AMERICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 165 SOUTH AMERICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 166 BRAZIL LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 167 BRAZIL DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026 (USD MILLION) TABLE 168 BRAZIL LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 169 BRAZIL LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 170 BRAZIL LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 171 REST OF SOUTH AMERICALDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 172 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 173 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 174 MIDDLE EAST AND AFRICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 175 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 176 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY DISTRIBUTION CHENNEL, 2017-2026 (USD MILLION) TABLE 177 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 178 SOUTH AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 179 SOUTH AFRICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 180 SOUTH AFRICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 181 SOUTH AFRICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 182 SOUTH AFRICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 183 REST OF MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
 

LIST OF FIGURES GLOBAL LDL TEST MARKET

FIGURE 1 GLOBAL LDL TEST MARKET: SEGMENTATION FIGURE 2 GLOBAL LDL TEST MARKET: DATA TRIANGULATION FIGURE 3 GLOBAL LDL TEST MARKET: DROC ANALYSIS FIGURE 4 GLOBAL LDL TEST MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS FIGURE 5 GLOBAL LDL TEST MARKET: COMPANY RESEARCH ANALYSIS FIGURE 6 GLOBAL LDL TEST MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 GLOBAL LDL TEST MARKET: DBMR MARKET POSITION GRID FIGURE 8 GLOBAL LDL TEST MARKET: THE MARKET CHALLENGE MATRIX FIGURE 9 GLOBAL LDL TEST MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL LDL TEST MARKET FIGURE 11 GLOBAL LDL TEST MARKET: SEGMENTATION FIGURE 12 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL LDL TEST MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026 FIGURE 13 INCREASING GERIATRIC POPULATION, INCREASING OBESITY AND OVERWEIGHT POPULATION ARE EXPECTED TO DRIVE THE GLOBAL LDL TEST MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 FIGURE 14 KITS AND REAGENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LDL TEST MARKET IN 2019 & 2026 FIGURE 15 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH-AMERICA IS HAVING MOST PROFITABLE REVENUE POCKETS FOR GLOBAL LDL TEST MARKET IN THE FORECAST PERIOD FROM 2019 TO 2026 FIGURE 16 GLOBAL LDL TEST MARKET: BY COMPONENT, 2018 FIGURE 17 GLOBAL LDL TESTING MARKET: BY DISEASE, 2018 FIGURE 18 GLOBAL LDL MARKET: BY DISTRIBUTION CHANNEL, 2018 FIGURE 19 GLOBAL LDL TEST MARKET: BY END USER, 2018 FIGURE 20 GLOBAL LDL TEST MARKET: SNAPSHOT (2018) FIGURE 21 GLOBAL LDL TEST MARKET: BY GEOGRAPHY (2018) FIGURE 22 GLOBAL LDL TEST MARKET: BY GEOGRAPHY (2019 & 2026) FIGURE 23 GLOBAL LDL TEST MARKET T: BY COUNTRY (2018 & 2026) FIGURE 24 GLOBAL LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 25 NORTH AMERICA LDL TEST MARKET: SNAPSHOT (2018) FIGURE 26 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2018) FIGURE 27 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2019 & 2026) FIGURE 28 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 29 NORTH AMERICA LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 30 EUROPE LDL TEST MARKET: SNAPSHOT (2018) FIGURE 31 EUROPE LDL TEST MARKET: BY COUNTRY (2018) FIGURE 32 EUROPE LDL TEST MARKET: BY COUNTRY (2019 & 2026) FIGURE 33 EUROPE LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 34 EUROPE LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 35 ASIA-PACIFIC LDL TEST MARKET: SNAPSHOT (2018) FIGURE 36 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2018) FIGURE 37 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2019 & 2026) FIGURE 38 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 39 ASIA-PACIFIC LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 40 SOUTH AMERICA LDL TEST MARKET: SNAPSHOT (2018) FIGURE 41 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2018) FIGURE 42 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2019 & 2026) FIGURE 43 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 44 SOUTH AMERICA LDL TEST MARKET: BY COMPONENT (2019-2026) FIGURE 45 MIDDLE EAST AND AFRICA LDL TEST MARKET: SNAPSHOT (2018) FIGURE 46 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2018) FIGURE 47 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2019 & 2016) FIGURE 48 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 49 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 50 GLOBAL LDL TEST MARKET: COMPANY SHARE 2018 (%) FIGURE 51 NORTH AMERICA LDL TEST MARKET: COMPANY SHARE 2018 (%) FIGURE 52 EUROPE LDL TEST MARKET: COMPANY SHARE 2018 (%) FIGURE 53 ASIA PACIFIC LDL TEST MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART